Abstract
Objective: Colorectal cancer (CRC) is a significant global health concern with high morbidity and mortality rates. Early detection and accurate diagnostic tools are critical for improving patient outcomes. Our aim in this study was to investigate the diagnostic significance of specific biomarkers - secreted frizzled associated protein-4 (sFRP-4), trefoil factor-3 (TFF-3), nuclear factor-kappa-B (NF-κB), and reactive oxygen species modulator-1 (Romo1) - in patients with CRC. Methods: This study analyzed plasma levels of sFRP-4, TFF-3, NF-κB and Romo1 in a cohort of patients with CRC (n=50) and age- and gender-matched control group (n=40), utilizing ELISA. The diagnostic performance of these biomarkers was assessed through Receiver Operating Characteristic (ROC) analysis. Results: Our research revealed a significant increase in the levels of NF-κB, TFF-3 and Romo1 in patients with a diagnosis of CRC. Furthermore, these parameters were found to maintain elevated levels in patients with tumours larger than 4 cm as opposed to those with smaller tumours. Patients with metastases also had elevated levels of the three parameters compared with patients without metastases. The ROC analysis revealed that NF-κB showed the most promise as a parameter for distinguishing patients from control subjects, whereas TFF-3 displayed the most potential in identifying tumour size and the presence of metastasis. Conclusions: This research contributes valuable insights into the development of non-invasive diagnostic approaches for CRC. The potential of NF-κB, TFF-3 and Romo1 as biomarkers offers a novel avenue for early detection and improved management of CRC, ultimately contributing to better patient outcomes. Further validation and prospective studies are warranted to establish the clinical utility of these biomarkers in CRC diagnosis and screening programs.

This publication has 38 references indexed in Scilit: